Welcome to Helix Talk, an educational podcast for healthcare students and providers covering real-life clinical pearls, professional pharmacy topics, and drug therapy discussions.

This podcast is provided by pharmacists and faculty members at Rosal Franklin University College of Pharmacy.

This podcast contains general information for educational purposes only. This is not professional

advice and should not be used in lieu of obtaining advice from a qualified health care provider.

And now on to the show. Welcome to Helix Talk, episode 188. I'm your co-host, Dr. Kane.

And I'm Dr. Patel. And the title of today's episode is

The Clot Thickens, Key Updates from the 2025 Acute Coronary Syndrome's Guidelines. So Dr. Patel,

today we're talking about guidelines that are fresh off the press that it's been a minute since

these have been updated. So kind of exciting to talk about what's new in ACS. Yeah, I believe the

last update was in 2013. And so it's what, 12 years since then?

We haven't seen much of the update, so I'm excited to talk about it.

It's freshly published.

What's kind of important here is that this is a consolidated update of a couple different guidelines that have come out over the years. So our STEMemmy, N-Stemmy, PCI for Stemmy, and then dual anti-platelet therapy guidelines,

which, you know, were released in different years and things like that.

This is designed to kind of consolidate all of those plus have new updates as well.

And usually guidelines can be pretty long read.

These are comparatively just 92 pages.

And I like, you know, that we handbook kind of like the most important pharmacotherapy related aspect,

but it has comprehensive management of ACS guidelines and approach. And of course, like we in our show notes

for again, episode 188 at

Helix Talk.com, we have references to the 92 page guideline. So why don't we start with one big

important section, which is the use of analgesics for chest pain. So when patients have an acute

...